advertisement

Topcon

Lee DY 12

Showing records 1 to 12 | Display all abstracts from Lee DY

125853 How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Kim M
Pharmaceutics 2024; 16:
126829 Age-related eye diseases and subsequent risk of mental disorders in older adults: A real-world multicenter study
Hwang G
Journal of Affective Disorders 2025; 375: 306-315
125853 How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Jung MY
Pharmaceutics 2024; 16:
126829 Age-related eye diseases and subsequent risk of mental disorders in older adults: A real-world multicenter study
Lee SH
Journal of Affective Disorders 2025; 375: 306-315
125853 How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Lee DY
Pharmaceutics 2024; 16:
126829 Age-related eye diseases and subsequent risk of mental disorders in older adults: A real-world multicenter study
Lee DY
Journal of Affective Disorders 2025; 375: 306-315
125853 How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Ahn SM
Pharmaceutics 2024; 16:
126829 Age-related eye diseases and subsequent risk of mental disorders in older adults: A real-world multicenter study
Park C
Journal of Affective Disorders 2025; 375: 306-315
125853 How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Lee GM
Pharmaceutics 2024; 16:
126829 Age-related eye diseases and subsequent risk of mental disorders in older adults: A real-world multicenter study
Roh HW
Journal of Affective Disorders 2025; 375: 306-315
125853 How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Park CY
Pharmaceutics 2024; 16:
126829 Age-related eye diseases and subsequent risk of mental disorders in older adults: A real-world multicenter study
Son SJ; Park RW
Journal of Affective Disorders 2025; 375: 306-315

Issue 25-2

Change Issue


advertisement

WGA Rescources